Drugmaker Sues To Invalidate Rival MS Patent In UK
Generic drugmaker Teva Pharmaceutical has sued Sanofi-Aventis in London in an attempt to get its rival's patent for a multiple sclerosis medicine invalidated, arguing that Sanofi's invention was obvious considering other...To view the full article, register now.
Already a subscriber? Click here to view full article